Description
DECA 200 (Nandrolone Decanoate) 200 mg Evo Genetics
Product Description
DECA 200 (Nandrolone Decanoate) 200 mg Evo Genetics is a high-quality anabolic steroid that is widely used by athletes and bodybuilders to enhance their performance and achieve their fitness goals. This product is manufactured by Evo Genetics, a reputable pharmaceutical company known for its commitment to producing safe and effective steroids.
Specific Details
- Active Ingredient: Nandrolone Decanoate
- Strength: 200 mg per ml
- Quantity: 10 ml vial
- Manufacturer: Evo Genetics
Features and Benefits
DECA 200 offers numerous benefits to athletes and bodybuilders:
- Promotes muscle growth and strength
- Enhances protein synthesis
- Improves nitrogen retention
- Increases red blood cell production
- Boosts collagen synthesis, promoting joint health
- Enhances recovery and reduces muscle fatigue
Possible Side Effects
While DECA 200 is generally well-tolerated, it may cause some side effects, including:
- Estrogenic side effects such as water retention and gynecomastia
- Androgenic side effects such as acne and hair loss
- Suppression of natural testosterone production
- Cardiovascular issues
- Liver toxicity (only with excessive doses)
Usage and Dosage
For beginners, a dosage of 200-400 mg per week is recommended, divided into two equal injections. Experienced athletes can increase the dosage to 400-600 mg per week. The cycle duration is typically 8-12 weeks. Post-cycle therapy (PCT) is essential to restore natural testosterone production.
Benefits for the Buyer
By purchasing DECA 200 from our online sports pharmacy Steroideapothekeerfahrungen in Germany, customers can enjoy the following benefits:
- High-quality product from a reputable manufacturer
- Competitive pricing
- Discreet packaging and secure delivery
- Wide range of other steroids and supplements available
- Professional customer support
Choose Steroideapothekeerfahrungen for your steroid needs and experience the benefits of DECA 200 for yourself!
Reviews
There are no reviews yet.